Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia
Bedaquiline is currently a key drug for treating multidrug-resistant or rifampin-resistant tuberculosis. We report and discuss the unusual development of resistance to bedaquiline in a teenager in Namibia, despite an optimal background regimen and adherence. The report highlights the risk for bedaq...
Збережено в:
| Автори: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Centers for Disease Control and Prevention
2024-03-01
|
| Серія: | Emerging Infectious Diseases |
| Предмети: | |
| Онлайн доступ: | https://wwwnc.cdc.gov/eid/article/30/3/24-0134_article |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|